Clinical application of two class 1 new drugs in Guangdong dongyangguang Pharmaceutical Co., Ltd
-
Last Update: 2020-04-03
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
According to the website of the State Food and drug administration, Guangdong dongyangguang Pharmaceutical Co., Ltd applied for the clinical approval of two class 1 new drugs, respectively, laelotinib mesylate capsule and imitavir phosphate capsule, for the treatment of tumor and influenza respectively There is no domestic manufacturer of the above-mentioned drugs, and only dongyangguang Pharmaceutical Co., Ltd has applied for clinical application Guangdong dongyangguang Pharmaceutical Co., Ltd is a subsidiary of dongyangguang aluminum Dongyangguang aluminum is mainly engaged in large-scale professional hydrophilic foil production enterprises The pharmaceutical industry is one of the company's core businesses Yichang Changjiang pharmaceutical, another subsidiary of dongyangguang aluminum, is one of the domestic manufacturers of oseltamivir (Tamiflu) Oseltamivir can be used for the early treatment of h7n9 avian influenza virus During the SARS in 2009, the company obtained a large number of government purchase orders.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
